Cargando…
Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009273/ https://www.ncbi.nlm.nih.gov/pubmed/33786655 http://dx.doi.org/10.1007/s00330-021-07727-x |
_version_ | 1783672847298723840 |
---|---|
author | Li, Liang Wang, Li Zeng, Feifei Peng, Gongling Ke, Zan Liu, Huan Zha, Yunfei |
author_facet | Li, Liang Wang, Li Zeng, Feifei Peng, Gongling Ke, Zan Liu, Huan Zha, Yunfei |
author_sort | Li, Liang |
collection | PubMed |
description | OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness. RESULTS: Sixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843–0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796–0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761–0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708–0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703–0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581–0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone. CONCLUSIONS: The CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy. KEY POINTS: • Radiomics can be applied in CT images of COVID-19 and radiomics signature was an independent predictor of severe COVID-19. • CT-based radiomics model can predict severe COVID-19 with satisfactory accuracy compared with subjective CT findings and clinical factors. • Radiomics nomogram integrated with the radiomics signature, subjective CT findings, and clinical factors can achieve better severity prediction with improved diagnostic performance. |
format | Online Article Text |
id | pubmed-8009273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-80092732021-03-31 Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia Li, Liang Wang, Li Zeng, Feifei Peng, Gongling Ke, Zan Liu, Huan Zha, Yunfei Eur Radiol Imaging Informatics and Artificial Intelligence OBJECTIVES: To develop and validate a radiomics nomogram for timely predicting severe COVID-19 pneumonia. MATERIALS AND METHODS: Three hundred and sixteen COVID-19 patients (246 non-severe and 70 severe) were retrospectively collected from two institutions and allocated to training, validation, and testing cohorts. Radiomics features were extracted from chest CT images. Radiomics signature was constructed based on reproducible features using the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm with 5-fold cross-validation. Logistic regression modeling was employed to build different models based on quantitative CT features, radiomics signature, clinical factors, and/or the former combined features. Nomogram performance for severe COVID-19 prediction was assessed with respect to calibration, discrimination, and clinical usefulness. RESULTS: Sixteen selected features were used to build the radiomics signature. The CT-based radiomics model showed good calibration and discrimination in the training cohort (AUC, 0.9; 95% CI, 0.843–0.942), the validation cohort (AUC, 0.878; 95% CI, 0.796–0.958), and the testing cohort (AUC, 0.842; 95% CI, 0.761–0.922). The CT-based radiomics model showed better discrimination capability (all p < 0.05) compared with the clinical factors joint quantitative CT model (AUC, 0.781; 95% CI, 0.708–0.843) in the training cohort, the validation cohort (AUC, 0.814; 95% CI, 0.703–0.897), and the testing cohort (AUC, 0.696; 95% CI, 0.581–0.796). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics model outperformed the clinical factors model and quantitative CT model alone. CONCLUSIONS: The CT-based radiomics signature shows favorable predictive efficacy for severe COVID-19, which might assist clinicians in tailoring precise therapy. KEY POINTS: • Radiomics can be applied in CT images of COVID-19 and radiomics signature was an independent predictor of severe COVID-19. • CT-based radiomics model can predict severe COVID-19 with satisfactory accuracy compared with subjective CT findings and clinical factors. • Radiomics nomogram integrated with the radiomics signature, subjective CT findings, and clinical factors can achieve better severity prediction with improved diagnostic performance. Springer Berlin Heidelberg 2021-03-30 2021 /pmc/articles/PMC8009273/ /pubmed/33786655 http://dx.doi.org/10.1007/s00330-021-07727-x Text en © European Society of Radiology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Imaging Informatics and Artificial Intelligence Li, Liang Wang, Li Zeng, Feifei Peng, Gongling Ke, Zan Liu, Huan Zha, Yunfei Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia |
title | Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia |
title_full | Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia |
title_fullStr | Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia |
title_full_unstemmed | Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia |
title_short | Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia |
title_sort | development and multicenter validation of a ct-based radiomics signature for predicting severe covid-19 pneumonia |
topic | Imaging Informatics and Artificial Intelligence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009273/ https://www.ncbi.nlm.nih.gov/pubmed/33786655 http://dx.doi.org/10.1007/s00330-021-07727-x |
work_keys_str_mv | AT liliang developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia AT wangli developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia AT zengfeifei developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia AT penggongling developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia AT kezan developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia AT liuhuan developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia AT zhayunfei developmentandmulticentervalidationofactbasedradiomicssignatureforpredictingseverecovid19pneumonia |